Fortress Biotech (FBIO) Short-Term Debt repayments (2022 - 2024)
Historic Short-Term Debt repayments for Fortress Biotech (FBIO) over the last 4 years, with Q4 2024 value amounting to $5.0 million.
- Fortress Biotech's Short-Term Debt repayments fell 6580.03% to $5.0 million in Q4 2024 from the same period last year, while for Sep 2025 it was $19.6 million, marking a year-over-year increase of 3432.63%. This contributed to the annual value of $10.0 million for FY2024, which is 3151.63% down from last year.
- Latest data reveals that Fortress Biotech reported Short-Term Debt repayments of $5.0 million as of Q4 2024, which was down 6580.03% from -$50000.0 recorded in Q3 2024.
- Fortress Biotech's 5-year Short-Term Debt repayments high stood at $14.6 million for Q4 2023, and its period low was -$50000.0 during Q3 2024.
- For the 3-year period, Fortress Biotech's Short-Term Debt repayments averaged around $4.9 million, with its median value being $5.0 million (2022).
- Data for Fortress Biotech's Short-Term Debt repayments shows a peak YoY increase of 6580.03% (in 2024) and a maximum YoY decrease of 490000.0% (in 2024) over the last 5 years.
- Quarter analysis of 3 years shows Fortress Biotech's Short-Term Debt repayments stood at $5.0 million in 2022, then skyrocketed by 192.4% to $14.6 million in 2023, then crashed by 65.8% to $5.0 million in 2024.
- Its Short-Term Debt repayments stands at $5.0 million for Q4 2024, versus -$50000.0 for Q3 2024 and $14.6 million for Q4 2023.